Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The relationship between post-diagnostic statin usage and breast cancer prognosis varies by hormone receptor phenotype: a systemic review and meta-analysis.

Archives of gynecology and obstetrics - 1 Nov 2021

Xu Wen-Huan, Zhou Yun-Hai

Abstract excerpt

BACKGROUND: Preclinical studies and epidemiologic data had indicated statins had antineoplastic properties in breast cancer patients. Since breast cancer treatment is based on its phenotype, it is important to explore influence of post-diagnosis statin usage on breast cancer patients with different phenotypes. METHODS: We searched the related studies between inception and August, 2019 from MEDLINE and EMBASE. A...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Hormones
Share to Hydroxymethylglutaryl-CoA Reductase Inhibitors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Phenotype

Share to Prognosis

Source

Identifiers

PMID: 33891208
DOI: 10.1007/s00404-021-06065-z

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The relationship between post-diagnostic statin usage and breast cancer prognosis varies by hormone receptor phenotype: a systemic review and meta-analysis.PMID 33891208Read ↗

Trends in the Incidence and Survival of Women with Hormone Receptor-Positive Breast Cancer from 1990–2019: A Large Population-Based AnalysisSemantic proximity Read ↗

High expression of cholesterol biosynthesis genes is associated with resistance to statin treatment and inferior survival in breast cancerSemantic proximity Read ↗

Comparison of Changes in Lipid Profiles of Eastern Chinese Premenopausal Women with Early-Stage Breast Cancer Treated with Different Endocrine Therapy: A Retrospective StudySemantic proximity Read ↗

Global Transcriptional Changes Following Statin Treatment in Breast CancerSemantic proximity Read ↗

Potential Predictive Factors for Breast Cancer Subtypes from a North Cyprus Cohort AnalysisSemantic proximity Read ↗

Immunohistochemical Phenotype of Breast Cancer during 25-Year Follow-up of the Royal Marsden Tamoxifen Prevention Trial.Semantic proximity Read ↗

Predictive pharmacogenetic biomarkers for breast cancer recurrence prevention by simvastatin.Semantic proximity Read ↗

Metformin for the treatment of breast cancer: a scoping review of randomized clinical trialsSemantic proximity Read ↗

Population‐based study of the effect of gene expression profiling on adjuvant chemotherapy use in breast cancer patients under the age of 65 yearsSemantic proximity Read ↗

The association between serum lipid levels and histological type of breast cancerSemantic proximity Read ↗

Hormone-replacement therapy influences gene expression profiles and is associated with breast-cancer prognosis: a cohort studySemantic proximity Read ↗

Simvastatin affects EMT and stemness phenotype of triple negative breast cancer cellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.